In its announcement, the White House said the cost of Ozempic, Wegovy and Zepbound will fall to roughly $350 a month when purchased through TrumpRx
Changes persist with continued use of the drug
Persistent or severe abdominal pain, particularly in the right upper quadrant where the liver is located, requires medical assessment
Introduced by Novo Nordisk in 2026, it's the first oral GLP-1 medication specifically approved for weight loss and is distinct from Rybelsus, which is for type 2 diabetes
The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomized, double-blind, placebo-controlled trial
It's an investigational drug in Phase 3 clinical trials Expected availability: 2027-2028 after FDA approval, assuming Phase 3 trials complete successfully Current access options: Clinical trial enrollment (free), compounding pharmacies with prescription ($200-500/month), or research peptides ($150-500/month) By country: Not approved in US, UK, EU, Australia, or Canada